AIRA Matrix CEO Chaith Kondragunta to deliver speech at Intelligent Health Inspired Online Summit

Mumbai, May 15, 2020

AIRA Matrix CEO, Chaith Kondragunta will be speaking at Intelligent Health Inspired, the world’s largest online summit dedicated to AI in medicine. The session titled, “AI Applications for Screening and Early Disease Detection in Pathology” is a part of the AI Innovation series.

Chaith will highlight the role of AI assisted decision support systems that help improve diagnostic outcomes. He will discuss how AIRA Matrix’s solutions optimize laboratory workflows, improve reporting turnaround times, and benefit treatment outcomes. Illustrative examples for clinical applications will include DL based solutions for automated adequacy assessment of EBUS-TBNA for lung malignancies and Gleason’s scoring in prostate carcinomas; examples for preclinical applications will highlight automated spermatogenic staging in reproductive toxicology. For more information on solutions that help in early detection, diagnosis and improved prognosis, see https://bit.ly/2xNQYAN and https://bit.ly/3e0zT7t.

To join the discussion, register at https://london.intelligenthealth.ai/inspired/.

Chaith Kondragunta

Chaith Kondragunta has several years’ experience leading analytics and AI based organizations.  He has founded and grown companies globally – from seed stage to public listing. Before AIRA Matrix he held several leadership positions, including CEO at AnalytixInisght, Inc and Managing Director at Stern Stewart & Co.

About AIRA Matrix

AIRA Matrix’s artificial intelligence solutions help improve efficiency, accuracy and    objectivity of image analysis in pharmaceutical, bio-research and healthcare industries.

Our services help optimize preclinical toxicology studies and reduce drug development times and costs.  Our solutions provide automated decision support to clinicians and improve treatment outcomes. Our products aid intelligent microbial environmental monitoring for regulatory requirements in pharma-manufacturing and clinical settings.

Source: AIRA Matrix Private Limited  www.airamatrix.com